SCOTTSDALE, AZ--(Marketwire - Feb 19, 2013) - AirWare Labs Corp. (OTCQB: [ AIRW ]) today shares the market outlook for its AIR® product lineup in context to products sold within the OTC (Over-the-Counter) and Natural/Homeopathic Marketplaces.

AIR® Product Overview

AIR® Patented Products start with an FDA approved medical grade silicone molded as an intranasal Air Breathe dilator; this is the AIR® delivery system. This microstructure enhances normal nasal airflow with every breath clinically proven to deliver up to 40% more oxygen. Certain AIR® products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria. AIR® Allergy and Travel products have additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, Allergens and bacteria. Other AIR® products specialize in helping with congestion, insomnia, headaches, nausea, snoring and performance enhancements. The AirWare Labs Products are marketed under the names: AIR® Sleep/Snore, AIR® Breathe, AIR® Allergy, AIR® Decongest, AIR® Headache, AIR® Nausea, AIR® Travel and AIR® Sport.

AIR® Product Market Opportunities

Market Research indicates that sales of products for the leading ailments (Flu, Cough, Cold, Allergy, Sleep Disorders, Headache and Nausea are approximately $4 Billion. These sales figures represent both the Over-the-Counter and the Natural/Homeopathic Markets. Additionally, it is also estimated that approximately 169 Million People are affected by these ailments seasonally or throughout the year -- and in the case of some ailments all year long.

Due to this massive market potential, AirWare Labs will launch this month its online marketing efforts to expand awareness to drive online sales as well as in-store sales at over 10,000 retail locations with national drug store chains. This campaign will utilize search-marketing terms that answer the millions of online searches seeking protection and relief from a variety of ailments. Demand alone for products that defend against the Flu and Allergies are at record levels. Current Internet searches are at meteoric heights that coincide with the CDC trends reporting influenza activity remaining very high and widespread nationally.

AIR® Products have a unique approach of increasing your oxygen intake, defending against viruses and promoting reduction against symptoms of common ailments. Unlike the masks you sometimes see in other countries to protect from -- and against -- germs from co-workers and the general public we have a discrete and better solution. AIR's® Filtered products offer increased intranasal protection where it's believed that flu is often contracted. Once customers experience the healthy by-product of increased oxygen flow, decreased air pollutants and the wellness benefits of essential therapeutic oils in AIR® products, we are confident our products will quickly become the preferred choice for drug-free relief for common ailments and sleepless nights.

About AirWare Labs Corporation

AirWare Labs ([ www.airwarelabs.com ]) provides patented & innovative technology solutions to consumer products promoting better health and enhanced wellbeing. AirWare Labs' products are marketed under the family name of AIR® by AirWare Labs. AIR® Products start with an FDA approved medical grade silicone molded as an intranasal Air Breathe dilator; this is the AIR® delivery system. This microstructure enhances normal nasal airflow with every breath clinically proven to deliver up to 40% more oxygen. Certain AIR® products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria. AIR® Allergy and Travel products have additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, Allergens and bacteria. Other AIR® products specialize in helping with congestion, insomnia, headaches, nausea, snoring and performance enhancements.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including the Company's beliefs about its business prospects and future results of operations. These results may not indicative of the result achieved in the entire tailings pile do to the non-homogenous nature of the pile itself. Some factors that could cause actual results to differ materially include economic and operational risks, changes in anticipated earnings, continuation of current contracts, and other factors detailed in the Company's filings with the Securities and Exchange Commission, including its most recent Forms 10-KSB and 10-QSB. The Company forecasts provided above are dynamic and therefore refer only to this release date. The Company does not undertake to update any forecasts that it may make available to the investing public. Please visit airwarelabscorp.com